These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32817603)

  • 1. Overdose Education and Naloxone Distribution Within Syringe Service Programs - United States, 2019.
    Lambdin BH; Bluthenthal RN; Wenger LD; Wheeler E; Garner B; Lakosky P; Kral AH
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1117-1121. PubMed ID: 32817603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.
    Lambdin BH; Bluthenthal RN; Garner BR; Wenger LD; Browne EN; Morris T; Ongais L; Megerian CE; Kral AH
    Implement Sci; 2024 Feb; 19(1):22. PubMed ID: 38419058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of opioid overdose education and naloxone distribution in New York City.
    Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
    Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
    Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A
    BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach.
    Wenger LD; Doe-Simkins M; Wheeler E; Ongais L; Morris T; Bluthenthal RN; Kral AH; Lambdin BH
    Harm Reduct J; 2022 May; 19(1):55. PubMed ID: 35643444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study.
    Lambdin BH; Wenger L; Bluthenthal R; Bartholomew TS; Tookes HE; LaKosky P; O'Neill S; Kral AH
    Harm Reduct J; 2023 Feb; 20(1):26. PubMed ID: 36855181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.
    Pauly JB; Vartan CM; Brooks AT
    Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprint of: Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
    Alexander M; Hooker J; Stratton M; Huh M; Houck K
    J Am Pharm Assoc (2003); 2024; 64(4S):102168. PubMed ID: 39127946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
    Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
    BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
    Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
    Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
    Alexander M; Hooker J; Stratton M; Huh M; Houck K
    J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model.
    Knudsen HK; Freeman PR; Oyler DR; Oser CB; Walsh SL
    Addict Sci Clin Pract; 2023 Nov; 18(1):72. PubMed ID: 38031180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study.
    Knudsen HK; Walker DM; Mack N; Kinnard EN; Huerta TR; Glasgow L; Gilbert L; Garner BR; Dasgupta A; Chandler R; Walsh SL; Tin Y; Tan S; Sprunger J; Sprague-Martinez L; Salsberry P; Saucier M; Rudorf M; Rodriguez S; Oser CB; Oga E; Nakayima J; Linas BS; Lefebvre RC; Kosakowski S; Katz RE; Hunt T; Holman A; Holloway J; Goddard-Eckrich D; Fareed N; Christopher M; Aldrich A; Adams JW; Drainoni ML
    Prev Med; 2024 Aug; 185():108034. PubMed ID: 38857770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racialized environments and syringe services program implementation: County-level factors.
    Bluthenthal RN; Humphrey JL; Strack CN; Wenger LD; LaKosky P; Patel SV; Kral AH; Lambdin B
    Drug Alcohol Depend; 2024 Oct; 263():112430. PubMed ID: 39216198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.